SEC Form 4 · accession 0001645627-18-000059
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 14, 2018
Accepted (ET)
Sep 20, 2018 · 12:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 14, 2018 | P | 1,000 | $0.0427 | A | 25,917,798 | D | |
| Common Stock | Sep 14, 2018 | P | 1,000 | $0.0441 | A | 25,918,798 | D | |
| Common Stock | Sep 14, 2018 | P | 1,000 | $0.0435 | A | 25,919,798 | D | |
| Common Stock | Sep 14, 2018 | P | 1,000 | $0.0435 | A | 25,920,798 | D | |
| Common Stock | Sep 17, 2018 | P | 1,000 | $0.0426 | A | 25,921,798 | D | |
| Common Stock | Sep 17, 2018 | P | 1,000 | $0.0424 | A | 25,922,798 | D | |
| Common Stock | Sep 17, 2018 | P | 1,000 | $0.0424 | A | 25,923,798 | D | |
| Common Stock | Sep 17, 2018 | P | 1,000 | $0.0424 | A | 25,924,798 | D | |
| Common Stock | Sep 17, 2018 | P | 2,000 | $0.0432 | A | 25,926,798 | D | |
| Common Stock | Sep 17, 2018 | P | 2,000 | $0.0432 | A | 25,928,798 | D |
Table II — derivative securities
No Table II lines on this filing.